跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HELIUM USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HELIUM USP
Authorized
STANDARD
HELIUM USP
Linde Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0f0d3ae0e6fd845f
Company
Linde Canada Inc
Type
Standard
Approval Details
Approval Id
0f0d3ae0e6fd845f
Drug Approval Canada Name
HELIUM USP
Product Name
HELIUM USP
Status
Marketed
Status Date
2022-05-04
Original Market Date
1993-12-31
Din
02014475
Drug Class
Human
Dosage Form
Gas
Route Of Administration
Inhalation
Schedule
Ethical
Ahfs
92:92.00
Atc Original
V03AN03 HELIUM
Atc Name
v 03 an 03
Aig Number
0115495001
Company Name
Linde Canada Inc
Company Address
500, 5015 Spectrum Way, Mississauga, Ontario, Canada, L4W 0E4
Company Detail Path
/organization/linde-canada-inc
Company Information
Pharmaceutical Company Name
Linde Canada Inc
Country Name
Canada
Province Name
British Columbia
City Name
victoria,british columbia,country_ca
Address
774 Fairview Rd
Active Ingredients
HELIUM
99 % / V/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0f0d3ae0e6fd845f
Type
Standard
Back to Health Canada Approvals